Preventive effects of calcitriol on the development of capsular invasive carcinomas in a rat two-stage thyroid carcinogenesis model

Journal of Veterinary Medical Science

Volumn 73, Issue 5, 2011, Pages 655-664

  Kemmochi, Sayaka ^a,b   Fujimoto, Hitoshi ^c   Woo, Gye Hyeong ^c   Hirose, Masao ^d   Nishikawa, Akiyoshi ^c   Mitsumori, Kunitoshi ^a   Shibutani, Makoto ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d Food Safety Commission of Japan   (Japan)

Author keywords

Calcitriol (1 , 25 dihydroxyvitamin D3); P27Kip1; Phosphoinositide 3 kinase Akt signaling; Sulfadimethoxine; Thyroid carcinogenesis

Indexed keywords

CALCITRIOL; CALCIUM CHANNEL STIMULATING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SULFADIMETHOXINE;

ANIMAL; APOPTOSIS; ARTICLE; BODY WEIGHT; CARCINOMA; DRUG EFFECT; FISCHER 344 RAT; MALE; METABOLISM; RAT; SIGNAL TRANSDUCTION; THYROID TUMOR;

ANIMALS; APOPTOSIS; BODY WEIGHT; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CARCINOMA; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION; SULFADIMETHOXINE; THYROID NEOPLASMS;

RATTUS;

EID: 79958072270     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.10-0415     Document Type: Article

References (30)

1. Akamizu, T., Ikuyama, S., Saji, M., Kosugi, S., Kozak, C., McBride, O. W. and Kohn, L. D. 1990. Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: Expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. Proc. Natl. Acad. Sci. U.S.A. 87: 5677-16781.
2. Ago, K., Saegusa, Y., Nishimura, J., Dewa, Y., Kemmochi, S., Kawai, M., Harada, T., Mitsumori, K. and Shibutani, M. 2010. Involvement of glycogen synthase kinase-3β signaling and aberrant nucleocytoplasmic localization of retinoblastoma protein in tumor promotion in a rat two-stage thyroid carcinogenesis model. Exp. Toxicol. Pathol. 62: 269-280.
3. Bao, B. Y., Ting, H. J., Hsu, J. W., Yasmin-Karim, S., Messing, E. and Lee, Y.F. 2010. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. J. Steroid. Biochem. Mol. Biol. 120:11-21.
4. Beer, T. M. and Myrthue, A. 2004. Calcitriol in cancer treatment: from the lab to the clinic. Mol. Cancer Ther. 3: 373-381.
5. Brewer, C., Yeager, N. and Di Cristofano, A. 2007. Thyroidstimulating hormone initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT. Cancer Res. 67: 8002-8006.
6. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
7. Johnson, C. S., Muindi, J. R., Hershberger, P. A. and Trump, D. L. 2006. The antitumor efficacy of calcitriol: preclinical studies. Anticancer Res. 26: 2543-2549.
8. Dackiw, A. P., Ezzat, S., Huang, P., Liu, W. and Asa, S. L. Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer. 2004. Endocrinology 145: 5840-5846.
9. El Abdaimi, K., Dion, N., Papavasiliou, V., Cardinal, P. E., Binderup, L., Goltzman, D., Ste-Marie, L. G. and Kremer, R. 2000. The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res. 60: 4412-4418.
10. Geng, Y., Yu, Q., Sicinska, E., Das, M., Bronson, R. T. and Sicinski, P. 2001. Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98: 194-199.
11. Gulubova, M. and Vlaykova, T. 2006. Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors α5β 1 and α9β 1 in gastric and colorectal cancers with lymph node and liver metastases. Acta Histochem. 108: 25-35.
12. Guyton, K. Z., Kensler, T. W. and Posner, G. H. 2003. Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr. Rev. 61: 227-238.
13. Hershberger, P. A., Modzelewski, R. A., Shurin, Z. R., Rueger, R. M., Trump, D. L. and Johnson, C. S. 1999. 1α, 25-Dihydroxycholecalciferol (1α, 25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21Waf1/Cip1 in vitro and in vivo. Cancer Res. 59: 2644-2649.
14. Imai, T., Onose, J., Hasumura, M., Ueda, M., Takizawa, T. and Hirose, M. 2004. Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation. Toxicol. Pathol. 32: 229-236.
15. Imai, T., Hasumura, M., Onose, J., Ueda, M., Takizawa, T., Cho, Y. M. and Hirose, M. 2005. Development of invasive follicular cell carcinomas in a rat thyroid carcinogenesis model: biological impact of capsular inflammation and reduced cyclooxygenase-2 expression. Cancer Sci. 96: 31-37.
16. Jensen, S. S., Madsen, M. W., Lukas, J., Binderup, L. and Bartek, J. 2001. Inhibitory effects of 1α, 25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery. Mol. Endocrinol. 15: 1370-1380.
17. Jiang, B. H. and Liu, L. Z. 2008. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim. Biophys. Acta 1784: 150-158.
18. Jiang, W., Zhu, Z. and Thompson, H. J. 2003. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosoureainduced mammary carcinomas in rats. Cancer Res. 63: 1228-1234.
19. Jiao, W., Lin, H. M., Datta, J., Braunschweig, T., Chung, J. Y., Hewitt, S. M. and Rane, S. G. 2008. Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation. Oncogene 27: 3156-3164.
20. Kemmochi, S., Fujimoto, H., Woo, G. H., Inoue, K., Takahashi, M., Mitsumori, K., Hirose, M., Nishikawa, A. and Shibutani, M. 2010. Involvement of PTEN/Akt signaling in capsular invasive carcinomas developed in a rat two-stage thyroid carcinogenesis model after promotion with sulfadimethoxine. J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-010-0931-7 (in press).
21. Liu, W., Asa, S. L. and Ezzat, S. 2005. 1α, 25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness. Mol. Endocrinol. 19: 2349-2357.
22. Lokeshwar, B. L., Schwartz, G. G., Selzer, M. G., Burnstein, K. L., Zhuang, S. H., Block, N. L. and Binderup, L. 1999. Inhibition of prostate cancer metastasis in vivo: a comparison of 1α, 23-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol. Biomarkers Prev. 8: 241-248.
23. LoPiccolo, J., Granville, C. A., Gills, J. J. and Dennis, P. A. 2007. Targeting Akt in cancer therapy. Anticancer Drugs. 18: 861-874.
24. Lundberg, A. S. and Weinberg, R. A. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell Biol. 18: 753-761.
25. Moffatt, K. A., Johannes, W. U., Hedlund, T. E. and Miller, G. J. 2001. Growth inhibitory effects of 1α, 25-dihydroxyvitamin D3 are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res. 61: 7122-7129.
26. Onodera, H., Mitsumori, K., Takahashi, M., Shimo, T., Yasuhara, K., Kitaura, K., Takahashi, M. and Hayashi, Y. 1994. Thyroid proliferative lesions induced by anti-thyroid drugs in rats are not always accompanied by sustained increases in serum TSH. J. Toxicol. Sci.19: 227-234.
27. Palmer, H. G., Sanchez-Carbayo, M., Ordonez-Moran, P., Larriba, M. J., Cordon-Cardo, C. and Munoz, A. 2003. Genetic signatures of differentiation induced by 1α, 25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res. 63: 7799-7806.
28. Paramio, J. M., Navarro, M., Segrelles, C., Gomez-Casero, E. and Jorcano, J. L. 1999. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene 18: 7462-7468.
29. Smith, P., Williams, E. D. and Wynford-Thomas, D. 1987. In vitro demonstration of a TSH-specific growth desensitising mechanism in rat thyroid epithelium. Mol. Cell Endocrinol. 51: 51-58.
30. Srivastava, A. K. and Pandey, S. K. 1998. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol. Cell Biochem. 182: 135-141.